BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33968078)

  • 1. CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade.
    Sundqvist KG
    Front Immunol; 2021; 12():670864. PubMed ID: 33968078
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.
    Bergström SE; Uzunel M; Talme T; Bergdahl E; Sundqvist KG
    Immunology; 2015 Apr; 144(4):687-703. PubMed ID: 25393517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.
    Panezai J; Bergdahl E; Sundqvist KG
    Immunology; 2017 Oct; 152(2):308-327. PubMed ID: 28580688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist.
    Thaventhiran T; Alhumeed N; Yeang HX; Sethu S; Downey JS; Alghanem AF; Olayanju A; Smith EL; Cross MJ; Webb SD; Williams DP; Bristow A; Ball C; Stebbings R; Sathish JG
    MAbs; 2014; 6(5):1290-9. PubMed ID: 25517314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.
    Bergström SE; Bergdahl E; Sundqvist KG
    Immunology; 2013 Dec; 140(4):441-55. PubMed ID: 23866045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.
    Römer PS; Berr S; Avota E; Na SY; Battaglia M; ten Berge I; Einsele H; Hünig T
    Blood; 2011 Dec; 118(26):6772-82. PubMed ID: 21931118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.
    Panoskaltsis N; McCarthy NE; Stagg AJ; Mummery CJ; Husni M; Arebi N; Greenstein D; Price CL; Al-Hassi HO; Koutinas M; Mantalaris A; Knight SC
    Cancer Immunol Immunother; 2021 Apr; 70(4):1127-1142. PubMed ID: 33033851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation.
    Bachmann MF; McKall-Faienza K; Schmits R; Bouchard D; Beach J; Speiser DE; Mak TW; Ohashi PS
    Immunity; 1997 Oct; 7(4):549-57. PubMed ID: 9354475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account.
    Hünig T
    FEBS J; 2016 Sep; 283(18):3325-34. PubMed ID: 27191544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two pathways of costimulation through CD28.
    Miller J; Baker C; Cook K; Graf B; Sanchez-Lockhart M; Sharp K; Wang X; Yang B; Yoshida T
    Immunol Res; 2009 Dec; 45(2-3):159-72. PubMed ID: 19214786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.
    Poirier N; Mary C; Le Bas-Bernardet S; Daguin V; Belarif L; Chevalier M; Hervouet J; Minault D; Ville S; Charpy V; Blancho G; Vanhove B
    MAbs; 2014; 6(3):697-707. PubMed ID: 24598534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models.
    Yan H; Bhagwat B; Sanden D; Willingham A; Tan A; Knapton AD; Weaver JL; Howard KE
    Toxicol Appl Pharmacol; 2019 Jun; 372():57-69. PubMed ID: 30914376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation: building an immunological synapse.
    Dustin ML; Shaw AS
    Science; 1999 Jan; 283(5402):649-50. PubMed ID: 9988658
    [No Abstract]   [Full Text] [Related]  

  • 14. CD28 signals the differential control of regulatory T cells and effector T cells.
    Mikami N; Sakaguchi S
    Eur J Immunol; 2014 Apr; 44(4):955-7. PubMed ID: 24652756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
    Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
    Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte costimulation mediated by reorganization of membrane microdomains.
    Viola A; Schroeder S; Sakakibara Y; Lanzavecchia A
    Science; 1999 Jan; 283(5402):680-2. PubMed ID: 9924026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of costimulation.
    Sharpe AH
    Immunol Rev; 2009 May; 229(1):5-11. PubMed ID: 19426211
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
    Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 co-receptor signal transduction in T-cell activation.
    Blair PJ; Riley JL; Carroll RG; St Louis DC; Levine BL; Saha B; Lee KP; Perrin PJ; Harlan DM; June CH
    Biochem Soc Trans; 1997 May; 25(2):651-7. PubMed ID: 9191174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.